These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8378535)

  • 1. Noncancer disease incidence in the atomic bomb survivors: 1958-1986.
    Wong FL; Yamada M; Sasaki H; Kodama K; Akiba S; Shimaoka K; Hosoda Y
    Radiat Res; 1993 Sep; 135(3):418-30. PubMed ID: 8378535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncancer disease incidence in atomic bomb survivors, 1958-1998.
    Yamada M; Wong FL; Fujiwara S; Akahoshi M; Suzuki G
    Radiat Res; 2004 Jun; 161(6):622-32. PubMed ID: 15161358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Prostate-Specific Antigen (PSA) Test on Radiation Risk Estimate for Prostate Cancer Incidence among Atomic-Bomb Survivors.
    Utada M; Brenner AV; Preston DL; Yamada M; Grant EJ; Sugiyama H; Sakata R; Cahoon EK; Ozasa K; Mabuchic K
    Radiat Res; 2023 Jul; 200(1):96-101. PubMed ID: 37141253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on the Japanese atomic bomb survivors of radiation received from the bombs.
    Cullings HM
    Health Phys; 2014 Feb; 106(2):281-93. PubMed ID: 24378504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
    Preston DL; Shimizu Y; Pierce DA; Suyama A; Mabuchi K
    Radiat Res; 2003 Oct; 160(4):381-407. PubMed ID: 12968934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of uterine myoma detected by ultrasound examination in the atomic bomb survivors.
    Kawamura S; Kasagi F; Kodama K; Fujiwara S; Yamada M; Ohama K; Oto K
    Radiat Res; 1997 Jun; 147(6):753-8. PubMed ID: 9189176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid cancer incidence in atomic bomb survivors: 1958-1998.
    Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
    Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological studies of atomic bomb radiation at the Radiation Effects Research Foundation.
    Ozasa K; Cullings HM; Ohishi W; Hida A; Grant EJ
    Int J Radiat Biol; 2019 Jul; 95(7):879-891. PubMed ID: 30676179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid diseases in atomic bomb survivors exposed in utero.
    Imaizumi M; Ashizawa K; Neriishi K; Akahoshi M; Nakashima E; Usa T; Tominaga T; Hida A; Sera N; Soda M; Fujiwara S; Yamada M; Maeda R; Nagataki S; Eguchi K
    J Clin Endocrinol Metab; 2008 May; 93(5):1641-8. PubMed ID: 18319305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.
    Furukawa K; Preston D; Funamoto S; Yonehara S; Ito M; Tokuoka S; Sugiyama H; Soda M; Ozasa K; Mabuchi K
    Int J Cancer; 2013 Mar; 132(5):1222-6. PubMed ID: 22847218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proportion of thyroid cancers in the Japanese atomic bomb survivors associated with natural background radiation.
    Little MP
    J Radiol Prot; 2002 Sep; 22(3):279-91. PubMed ID: 12375789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ; Hoel DG
    Radiat Res; 1992 May; 130(2):249-66. PubMed ID: 1574582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.